Covidien Ltd. (COV)
$45.65
0.52 (+1.15%)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $45.13 |
| Daily Range | $44.70 - $45.70 |
| 52-Week Range | $27.27 - $46.75 |
| Market Cap | $22.94B |
| P/E Ratio | 25.21 |
| Dividend (Yield) | 0.72 (1.60%) |
| Volume | 3,393,815 |
| Average Daily Volume | 2,332,000 |
COV
VS S&P 500 (SPY)
How do you think COV will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
COV Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
COV News and Commentary
- UPDATE 1-Covidien says FDA extends review of opiod pain drug – Reuters
- UPDATE 2-Covidien raises 2010 sales outlook, shares rise – Reuters
- UPDATE 1-Covidien Q4 profit beats estimates, ups sales views – Reuters
- The Stock Screaming "Buy Me!" – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- For Drugmakers, It's All In or Get Out – The Motley Fool
- UPDATE 1-Covidien to buy Aspect Medical for about $210 mln – Reuters
- UPDATE 1-US advisers back plan to monitor Covidien pain drug – Reuters
- US FDA staff see potential to abuse Covidien drug – Reuters
- Setting the Record Straight on Intel – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- 5 Stocks Approaching Greatness – The Motley Fool
- Wall Street's Buy List – The Motley Fool
- Rescue Your 401(k)! – The Motley Fool
- Should GE Be Broken Up? – The Motley Fool
- Best Stock for 2009: Somanetics – The Motley Fool
- The Market's 10 Best Stocks ... Cheap! – The Motley Fool
- Rochester Medical: A Medical Device Innovator – Blog at The Motley Fool
- 5 Stocks That Just Won't Quit – The Motley Fool
- Wounded by a Partner? – The Motley Fool
RSS Headlines
Fool UK
